Loading...

Repligen Corporation

RGEN•NASDAQ
Healthcare
Medical - Instruments & Supplies
$108.52
$4.32(4.15%)
U.S. Market opens in 13h 49m

Repligen Corporation (RGEN) Stock Overview

Explore Repligen Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap6.1B
P/E Ratio119.20
EPS (TTM)$0.91
ROE0.02%
Fundamental Analysis

AI Price Forecasts

1 Month$142.83
3 Months$108.26
1 Year Target$118.54

RGEN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Repligen Corporation (RGEN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 40.77, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $118.54.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 119.20 and a market capitalization of 6.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
4.14%
5-Day Change
1.38%
1-Month Change
-17.30%
3-Month Change
-20.92%
6-Month Change
-30.03%
Year-to-Date (YTD) Change
-33.78%
1-Year Change
-14.01%
3-Year Change
-31.86%
5-Year Change
-38.44%
All-Time (Max) Change
864.53%

Contact Information

https://www.repligen.com
781 250 0111
Building 1, Waltham, MA, 02453

Company Facts

1,778 Employees
IPO DateApr 29, 1986
CountryUS
Actively Trading

Frequently Asked Questions